Overview

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
This study was to find out if patients with Relapsing Remitting Multiple Sclerosis treated with Interferon beta-1a had an improved quality of life after treatment with Interferon beta-1a
Phase:
Phase 4
Details
Lead Sponsor:
Biogen
Treatments:
Interferon beta-1a
Interferon-beta
Interferons